(1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin
(1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin structure
|
Common Name | (1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin | ||
|---|---|---|---|---|
| CAS Number | 112465-00-6 | Molecular Weight | 1239.51000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C62H94N16O11 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Name | 1-adamantaneacetyl-d-tyr[o-ethyl]-phe-val-asn-abu-pro-arg-arg-nh2 |
|---|
| Molecular Formula | C62H94N16O11 |
|---|---|
| Molecular Weight | 1239.51000 |
| Exact Mass | 1238.73000 |
| PSA | 443.22000 |
| LogP | 6.27150 |
| InChIKey | LEXYSBQMSSPQTG-GZHSKDTOSA-N |
| SMILES | CCOc1ccc(CC(NC(=O)CC23CC4CC(CC(C4)C2)C3)C(=O)NC(Cc2ccccc2)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(CC)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(N)=O)C(C)C)cc1 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Arginine vasopressin enhances pHi regulation in the presence of HCO3- by stimulating three acid-base transport systems.
Nature 337(6208) , 648-51, (1989) Growth factors raise intracellular pH (pHi) by stimulating Na+/H+ exchange in the absence of HCO3-. In mutant cells that lack the Na+/H+ exchange activity, this alkalinization does not occur, and the ... |
|
|
Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
Circulation 107(18) , 2313-9, (2003) Vasodilatory shock is a potentially lethal complication of severe disease in critically ill patients. Currently, catecholamines are the most widely used vasopressor agents to support blood pressure, b... |
|
|
Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
J. Cereb. Blood Flow Metab. 25(8) , 1012-9, (2005) Brain edema formation is one of the most important mechanisms responsible for brain damage after ischemic stroke. Despite considerable efforts, no specific therapy is available yet. Arginine vasopress... |